Senter, Peter D.
Seagen, Inc.,
United States
2023 Rank: 46537
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Oncology & Carcinogenesis
SubField 2:
Organic Chemistry
Rank in SubField 1: 1635 out of 312644 Researchers
Data For The Year: 2023
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 46537 | 52126 |
| Total Cites | 815 | 824 |
| H-index | 15 | 16 |
| Hm-index | 6 | 6 |
| Number of Single Authored Papers | 3 | 3 |
| Total Cites to Single Authored Papers | 15 | 15 |
| Number of Single+First Authored Papers | 25 | 25 |
| Total Cites to Single+First Authored Papers | 72 | 73 |
| Number of Single+First+Last Authored Papers | 83 | 83 |
| Total Cites to Single+First+Last Authored Papers | 459 | 462 |
| Composite Score | 2 | 2 |
| Number of Distinct Citing Papers | 508 | 516 |
| Ratio of Total Citations to Distinct Citing Papers | 1.60 | 1.60 |
| Self-Citation Percentage |
1.09%
|
|
Senter, Peter D.
Seagen, Inc.,
United States
2022 Rank: 44269
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Oncology & Carcinogenesis
SubField 2:
Organic Chemistry
Rank in SubField 1: 1662 out of 293195 Researchers
Data For The Year: 2022
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 44269 | 50796 |
| Total Cites | 858 | 903 |
| H-index | 17 | 17 |
| Hm-index | 5 | 5 |
| Number of Single Authored Papers | 3 | 3 |
| Total Cites to Single Authored Papers | 10 | 10 |
| Number of Single+First Authored Papers | 25 | 25 |
| Total Cites to Single+First Authored Papers | 71 | 73 |
| Number of Single+First+Last Authored Papers | 81 | 81 |
| Total Cites to Single+First+Last Authored Papers | 494 | 519 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 545 | 556 |
| Ratio of Total Citations to Distinct Citing Papers | 1.57 | 1.62 |
| Self-Citation Percentage |
4.98%
|
|
Senter, Peter D.
Seagen,
United States
2021 Rank: 32201
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Oncology & Carcinogenesis
SubField 2:
Organic Chemistry
Rank in SubField 1: 1151 out of 271773 Researchers
Data For The Year: 2021
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 32201 | 35891 |
| Total Cites | 1473 | 1532 |
| H-index | 21 | 22 |
| Hm-index | 7 | 7 |
| Number of Single Authored Papers | 3 | 3 |
| Total Cites to Single Authored Papers | 23 | 23 |
| Number of Single+First Authored Papers | 25 | 25 |
| Total Cites to Single+First Authored Papers | 143 | 145 |
| Number of Single+First+Last Authored Papers | 81 | 81 |
| Total Cites to Single+First+Last Authored Papers | 845 | 878 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 883 | 898 |
| Ratio of Total Citations to Distinct Citing Papers | 1.67 | 1.71 |
| Self-Citation Percentage |
3.85%
|
|
Senter, Peter D.
Seattle Genetics, Inc.,
United States
2020 Rank: 24033
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Oncology & Carcinogenesis
SubField 2:
Organic Chemistry
Rank in SubField 1: 846 out of 230678 Researchers
Data For The Year: 2020
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 24033 | 27461 |
| Total Cites | 1228 | 1278 |
| H-index | 20 | 20 |
| Hm-index | 6 | 6 |
| Number of Single Authored Papers | 3 | 3 |
| Total Cites to Single Authored Papers | 20 | 20 |
| Number of Single+First Authored Papers | 25 | 25 |
| Total Cites to Single+First Authored Papers | 140 | 143 |
| Number of Single+First+Last Authored Papers | 81 | 81 |
| Total Cites to Single+First+Last Authored Papers | 723 | 750 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 685 | 699 |
| Ratio of Total Citations to Distinct Citing Papers | 1.79 | 1.83 |
| Self-Citation Percentage |
3.91%
|
|
Partner with TOPSCINET
Reach science enthusiasts and researchers across the site. Write to business@topscinet.com and our marketing team will send a proposal built around your banner ad goals.